Dysregulated genes in <i>BRIP1</i>-knockdown cells during acinar morphogenesis (ANOVA, <i>P</i><0.05; fold change ≥5.0). by Kazuhiro Daino (203837)

a) ECM components and collagen structure change with tumor progression, which influences cancer cell proliferation and metastasis. b) SHG visual representation of collagen patterns... by Zoë Dinkel (21402766)

Baseline characteristics of patients according to their CBS. by István Szegedi (11091230)

Subjects:

Baseline parameters and specific hemostasis markers according to short-term functional outcomes in the studied cohort. by István Szegedi (11091230)

Subjects:

Baseline parameters and specific hemostasis markers according to long-term functional outcomes in the studied cohort. by István Szegedi (11091230)

Subjects:

Independent predictors of unfavorable long-term outcome^a (mRS) in the total cohort. by István Szegedi (11091230)

Subjects:

Independent predictors of poor short-term outcome^a in the studied cohort. by István Szegedi (11091230)

Subjects:

ERPs (<i>μ</i>V) during the working memory task for preschool children. by Koji Kashihara (12475877)

ERPs (<i>μ</i>V) during the working memory task for young adults. by Koji Kashihara (12475877)

The activity of platelet P2Y1, but not of P2X1 or P2Y12 receptor, continually decreases in citrated WB. by Juergen Koessler (847843)

S5 Raw image - by Zhi Xuan Low (19270163)

Biallelic mutations in human <i>HBS1L</i> lead to Hbs1L deficiency and decreased Pelota protein. by Amy E. O’Connell (6288401)

Herceptin down-regulates HER2 receptors and decreases HER3 phosphorylation, but it does not decrease HER2 phosphorylation. by Merel Gijsen (234741)

A New Rotane Family:  Synthesis, Structure, Conformation, and Dynamics of [3.4]-, [4.4]-, [5.4]-, and [6.4]Rotane¹ by Lutz Fitjer (2466634)

“…At the same time their folding decreases, until in <b>8</b> they are close to planar. …”

Herceptin down-regulates HER2 receptors and decreases HER3 phosphorylation, but it does not decrease HER2 phosphorylation. by Merel Gijsen (234741)

Table 5_Temporal and spatial trends in gastric cancer burden in the USA from 1990 to 2021: findings from the global burden of disease study 2021.xlsx by Chengwei Zhan (18872651)

Data_Sheet_1_The origins and dynamic changes of C3- and S100A10-positive reactive astrocytes after spinal cord injury.PDF by Qing Zhao (170569)

“…RNA-seq and scRNA-seq results further confirmed that the transcripts of C3-positive reactive astrocytes and their lipid toxicity were gradually increased with time and age. In contrast, S100A10-positive reactive astrocytes transcripts increased at early time and then gradually decreased after SCI. …”

Histograms showing ranks of selected metrics. by Thomas Hopper (3216453)

Manganese chloride and cadmium chloride resulted in a decrease in the relative mtDNA:nDNA ratio. by Claudia P. González-Hunt (671616)

Lowering Melting Points in Asymmetrically Substituted Salen-Copper(II) Complexes Exhibiting Mesomorphic Behavior. Structure of the Mesogen Cu(5-hexyloxySalen) by Reinhard Paschke (553784)

“…In comparison with their symmetrical analogues, unsymmetrically substituted Cu−Salen complexes show mesophases with lowered melting points. For terminally substituted complexes, symmetrical ones (R¹ = R²) have only an S_A phase, while for unsymmetrical alkoxy substitution a monotropic S_E phase occurs and the melting temperature decreases with no loss in mesophase stability. …”